Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 13.9 USD 4.12% Market Closed
Market Cap: 8.3m USD

Intrinsic Value

QNRX doesn't have a meaningful market cap.

The intrinsic value of one QNRX stock under the Base Case scenario is 28.38 USD. Compared to the current market price of 13.9 USD, Quoin Pharmaceuticals Ltd is Undervalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

QNRX Intrinsic Value
28.38 USD
Undervaluation 51%
Intrinsic Value
Price
Q
Base Case Scenario

Valuation History
Quoin Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about QNRX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is QNRX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Quoin Pharmaceuticals Ltd.

Explain Valuation
Compare QNRX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about QNRX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Quoin Pharmaceuticals Ltd

Current Assets 6m
Cash & Short-Term Investments 5.4m
Other Current Assets 602.6k
Non-Current Assets 408.4k
Intangibles 408.3k
Other Non-Current Assets 100
Current Liabilities 5.8m
Accounts Payable 1.9m
Accrued Liabilities 3.3m
Short-Term Debt 600k
Other Current Liabilities 100
Non-Current Liabilities 1.9m
Long-Term Debt 1.9m
Efficiency

Free Cash Flow Analysis
Quoin Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Quoin Pharmaceuticals Ltd

Revenue
0 USD
Operating Expenses
-14.2m USD
Operating Income
-14.2m USD
Other Expenses
407.8k USD
Net Income
-13.8m USD
Fundamental Scores

QNRX Profitability Score
Profitability Due Diligence

Quoin Pharmaceuticals Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Quoin Pharmaceuticals Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

QNRX Solvency Score
Solvency Due Diligence

Quoin Pharmaceuticals Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
50/100
Solvency
Score

Quoin Pharmaceuticals Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QNRX Price Targets Summary
Quoin Pharmaceuticals Ltd

Wall Street analysts forecast QNRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QNRX is 42.5 USD with a low forecast of 25.25 USD and a high forecast of 73.5 USD.

Lowest
Price Target
25.25 USD
82% Upside
Average
Price Target
42.5 USD
206% Upside
Highest
Price Target
73.5 USD
429% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Quoin Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for QNRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

QNRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one QNRX stock?

The intrinsic value of one QNRX stock under the Base Case scenario is 28.38 USD.

Is QNRX stock undervalued or overvalued?

Compared to the current market price of 13.9 USD, Quoin Pharmaceuticals Ltd is Undervalued by 51%.

Back to Top